Thermo Fisher Scientific Clenoliximab Chimeric Recombinant Human Monoclonal Antibody (CE9.1 (Clenoliximab))

Applications

Tested Dilution

Publications

Immunohistochemistry (IHC)

Assay-dependent

-

Immunohistochemistry (Paraffin) (IHC (P))

3 µg/mL

-

Flow Cytometry (Flow)

Assay-dependent

-

ELISA (ELISA)

Assay-dependent

-

Inhibition Assays (IA)

Assay-dependent

-

Surface plasmon resonance (SPR)

Assay-dependent

-

Product Specifications

Species Reactivity

Chimpanzee, Human

Host/Isotype

Human / IgG4, lambda

Expression System

HEK293 cells

Class

Recombinant Monoclonal

Type

Antibody

Clone

CE9.1 (Clenoliximab)

Immunogen

Domain 1 of human CD4.

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Purification

Protein A

Storage buffer

PBS

Contains

0.02% ProClin 300

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Wet ice

Product Specific Information

The antibody binds to human CD4 with a Kd of 1.0 nM and an ED50 of 0.2 µg/mL.

Target Information

Clenoliximab is a chimeric monoclonal antibody fromMacaca irusagainst CD4 which acts as an immunomodulator. It has investigated for the treatment of rheumatoid arthritis.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.